You are here
- Home
Total number of clinical trials
- collapse A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib with Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers
- collapse A Phase I, Single-centre, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Different Extended Release Formulations of Tablets of AZD3241 (300 mg) after Administration of Multiple Doses in Healthy Male and Female Volunteers
- collapse An Open-label, Nonrandomised, Phase I Study to Assess the Pharmacokinetics of Ceftaroline After Intravenous Administration of aSingle Dose of Ceftaroline Fosamil (200 mg) to Patients With End-stage Renal Disease Undergoing Haemodialysis When Compared to a Single Dose of Ceftaroline Fosamil (600 mg).
- collapse AZD5069 Neutrophil Function Study
- collapse A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of the m-Tor Kinase Inhibitor AZD8055 Using Intermittent Dosing Schedules in Patients With Advanced Solid Malignancies and Lymphomas
- collapse Open label Positron Emission Tomography study with [18F]AZD4694 and [11C]AZD2184, candidate radioligands for AB amyloid, to determine and compare in vivo brain uptake and distribution in healthy volunteers and patients with Alzheimer's Disease
- collapse A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Healthy Subjects When Administered Alone and in Combination With a Single Dose of 800-mg Vandetanib (CAPRELSA)
- collapse A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of Digoxin in Healthy Subjects When Administered Alone and in Combination With a Single Dose of Vandetanib (CAPRELSA) 300 mg
- collapse A Phase I, Multi-centre, Two Part, Open Study to Assess the Safety and Tolerability of AZD2171 following Multiple Oral Doses in Patients with Relapsed or Refractory Acute Myeloid Leukaemia and Elderly Patients with De Novo or Secondary Acute Myeloid Leukaemia
- collapse A Phase I Single-centre 2-part Open Study to Assess the Safety and Tolerability of AZD2171 following Single and Multiple Oral Doses in Patients with Solid Malignant Tumours and Metastatic Liver Disease
